ASHP
  • Program
  • Registration
  • ASHP Spotlight
  • Midyear Coverage
  • Awards and Events
  • ASHP Marketplace
  • Meeting Info
  • Previews
Topics
  • ASHP Spotlight
  • Midyear Coverage
  • Awards and Events
  • ASHP Marketplace
  • Meeting Info
  • Previews
Resources
  • Program
  • Registration
Facebook iconTwitter iconLinkedIn iconInstagram icon
December 8, 2021

Big Changes Coming From USP and NIOSH

Don't miss this update.


Brenda Jensen and Jerald Ovesen
Brenda Jensen and Jerald Ovesen

Major changes are on the way from two of the governing entities for compounding of sterile and nonsterile preparations. During today’s special session, “2021 USP Compounding Chapter Revisions and the NIOSH List: Two ‘Can’t Miss’ Compounding Updates,” experts will update attendees on several critical areas.

Brenda Jensen, consultant with Compounding Consultants LLC in Sioux Falls, South Dakota, will present an overview of proposed revisions to the USP Compounding  standards—specifically Chapter 795 on nonsterile preparations and Chapter 797 on sterile preparations.

Both chapters, she said, have been going through the revision process for several years. Changes were proposed to USP 795 in 2018, receiving more than 2,000 public comments, while changes to USP 797, proposed first in 2015, received more than 8,000 public comments. Revisions to those changes published again in 2018 received more than 4,000 public comments.

Following publication of both updated chapters in June 2019, the changes went through a lengthy appeals process and the most recent proposed revisions were published in September of this year. The comment period on those revisions is open through Jan. 31, 2022, with two open forums scheduled for January as well.

Jensen will walk attendees through the most recent revisions and will provide information on how you can file your comments and make your voice heard before the deadline.

Meanwhile, Jerald Ovesen, pharmacologist for the Centers for Disease Control and Prevention (CDC) and the National Institute for Occupational Safety and Health (NIOSH), will attempt to answer some of the big questions surrounding the Draft 2020 NIOSH List of Hazardous Drugs.

“One of the biggest questions we get asked about the updated NIOSH list is, where is it?” he said.

Unfortunately, the answer to that question is a complicated one. Ovesen said the latest regularly scheduled update was announced in 2018 and numerous public comments were received at that time. Since then, NIOSH has been reviewing those comments and released a draft in 2020, but nothing has been finalized.

“The answer to that is no, it’s not finalized yet,” Ovesen said. “NIOSH received comments from more than 180 individual commenters in the public comments. NIOSH is currently responding to all those comments and making the appropriate changes to the documents. The NIOSH List of Antineoplastics and Other Hazardous Drugs, 2016 update, is still the current finalized list. We do not know at this time a release date for the finalized documents. We are still working on making the appropriate changes and getting it through the review process. The last two years have been a little slower at CDC for some things.”

That said, Ovesen will still walk attendees through what the list is, what is on it currently, how it is organized and what it should—and should not—be used for. He will also provide some insight into the content and new categories in the Draft 2020 NIOSH List.

Share Your Feedback on USP Chapters 797 and 795

ASHP encourages members to submit their own comments to USP, but is also inviting feedback for ASHP’s comments that will be submitted to USP on behalf of our members. Please use these links to share your feedback with ASHP:

  • USP General Chapter <795> feedback
  • USP General Chapter <797> feedback

These surveys will close Dec. 20, 2021 to allow time for analysis of submissions and synthesis of ASHP’s comments to USP by the Jan. 31, 2022 deadline.

 

 

Featured Stories
Geospatial Tools Offer Fresh Perspective on Patient Care
Sponsored by ASHP
Geospatial Tools Offer Fresh Perspective on Patient Care
ASHP announces new Leadership Center and Membership Group
Sponsored by ASHP
ASHP announces new Leadership Center and Membership Group
More Content
Close Up Hand Holding Covid 19 Vaccine 2021 08 28 03 48 08 Utc
ASHP Midyear 2021
FDA, CDC Experts Share COVID-19 Vaccine Progress
December 8, 2021
Thomas Lodise and Michael Rybak
ASHP Midyear 2021
Trough Levels Don’t Cut It for Vancomycin Dosing in Seriously Ill Patients
December 8, 2021
Getty Images 1344197992
ASHP Midyear 2021
Anti-Racism and Its Role in Achieving Health Equity
December 8, 2021
Getty Images 638044582
ASHP Midyear 2021
Don’t Get Caught Sleeping on 340B, Experts Say
December 8, 2021
Cyrine Haidar and Shannon Manzi
ASHP Midyear 2021
Pharmacogenomic Testing Can Benefit Children and Families
December 8, 2021
Tyler Vest
ASHP Midyear 2021
New Research Brings Changes to the Medication-Use Process
December 8, 2021
Terri Jorgenson and Lisa Kearney
ASHP Midyear 2021
An All Hands on Deck Approach for Mental Health and Pain Care
December 8, 2021
Cheyenne Frazier and Karen Gunning
ASHP Midyear 2021
Transgender Care Is Patient Care
December 8, 2021
From left: Andre D. Harvin, Patricia C. Kienle, and Clinton L. Meachum
ASHP Midyear 2021
Thursday’s Virtual Midday Symposia
December 8, 2021
Getty Images 1313783716
ASHP Midyear 2021
Highlights from 10th Annual Pharmacy Forecast Unveiled at Midyear
December 7, 2021
Jao Tribute Mdn
ASHP Midyear 2021
Remembering Joseph A. Oddis, a Giant in Pharmacy
December 7, 2021
Mdn Advocacy Text
ASHP Midyear 2021
States Pave the Way for Practice Advancement
December 7, 2021
ASHP
Facebook iconTwitter iconLinkedIn iconInstagram icon
© 2023 Ascend Media. All rights reserved.